Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 55%
Hold 9%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health Inc. demonstrated robust financial performance, with a gross profit of $269.0 million reflecting an 8% year-over-year growth, surpassing estimates. The chronic therapy segment showed significant expansion, exceeding 10%, indicating strong demand for its services. Additionally, the company raised its revenue guidance for 2025 to a range of $5.5 billion to $5.65 billion, projecting a 12% year-over-year increase at the midpoint, which underscores a positive outlook on future growth.

Bears say

The outlook for Option Care Health Inc. appears negative due to several financial pressures that could hinder future growth and profitability. A significant concern is the potential loss of its largest customer, which contributed 14% to 2023 revenue, posing a substantial risk to the company's overall earnings. Additionally, management highlighted challenges regarding gross margin expansion, particularly as the company shifts towards chronic therapies that traditionally yield lower margins, coupled with an anticipated gross profit headwind exceeding $20 million related to the Stelara product.

OPCH has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 55% recommend Buy, 9% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 11 analysts, OPCH has a Buy consensus rating as of Jan 1, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $36.45, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $36.45, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.